Global Value & Access strategy lead for Hematology and early oncology pipeline. Responsible for launch readiness for potential first-in-class immunotherapy, working in close collaboration with HEOR, pricing, marketing, medical, clinical and regulatory teams, in addition to key local market access teams.

Established and leading a high-performing access function, responsible for developing strategy & executing marketing tactics across all of TECENTRIQ’s approved and pipeline indications.• Partnering across multiple oncology franchises and serving as access partner on gynecology squad• Led cross-functional teams to develop and execute access launch strategies for recent TECENTRIQ combinations in HCC and melanoma, during significant field changes and virtual engagement• Developed TECENTRIQ’s non-clinical value proposition and messaging to increase field teams’ access competencies and improve customer perceptions

Leading team of 6 direct reports to partner cross-functionally and develop pricing, contracting, and distribution (PCD) strategies that impact multiple products in Genentech’s portfolio. Team responsibilities include value-based contracting, portfolio price changes, and community clinic discount program.• Actively participating on PCD’s leadership team and supporting team through significant organizational changes, while maintaining engagement and achieving business results • Developing cross-functional strategies to address high cost of oncology combination therapies• Developing pricing approach for rare disease therapies that was endorsed by US Commercial Leadership Team

Led global pricing and market access strategy for two hematology medicines (one marketed and one in late stage development).• Determined launch pricing and access assumptions for largest European markets; partnered closely with global business and country market access teams to ensure alignment• Developed strategy for engaging European payers along with health authorities on scientific advice; partnered closely with development and market access teams to develop aligned Roche perspective

Hired, coached, and developed multiple direct reports to advance portfolio-level pricing, contracting, and distribution (PCD) strategies. Team responsibilities include portfolio price changes and biosimilar defense strategies.• Created initial contracting strategy to defend against biosimilar competition; led cross-functional team to align on organizational objectives and develop segment-specific strategies, which were endorsed by Commercial executives; received 2017 BioOncology Marketing Excellence award • Developed internal and external pricing & reimbursement update for Pharma CEO through close partnership with head of Managed Care and Customer Operations (MCCO)

Managed all quarterly pricing updates for Genentech’s marketed products, including approval by US Commercial leadership; also led several cross-portfolio strategic pricing initiatives with US and global teams• Developed a risk assessment framework to evaluate the pricing challenges of oncology combination regimens; received US Oncology Leadership and Commercial Leadership endorsement• Created new approach and model to determine oncology drug prices (including allocation of value within combinations); received Commercial Leadership endorsement to use for all launch price and price increase decisions• Developed new value/risk-based pricing framework that increased rigor and transparency of pricing decisions for marketed products

* Internal portfolio reporting lead - developed portfolio updates on a quarterly basis and communicating up-to-date portfolio information as needed to senior executives* Analyzed portfolio performance and composition to understand key drivers and potential opportunities* Partnered with Pharma COO and CMO to provide portfolio and Emerging Market updates to Roche Board of Directors* Managed the launch and on-going business operations of Roche’s portfolio systems, partnering with functional leads across diverse business units and geographies

Leading high-level strategic organizational direction with board members from top investment banks, consulting firms, and business schools. Managing all aspects of conference planning including marketing, sponsorship, program, scholarship, and logistics. Results include:* Increased student attendance by 25% and corporate sponsorship by over 30% as Executive Director* Continue to support significant growth (attendance and financial) of organization and developing new strategic vision

Independent strategy consultant, leveraging broad functional and industry expertise with private equity clients and industry leaders. Selected engagements include:* Conducting an extensive due diligence of the coffee category for a potential acquisition by an industry leader, including overall category economics, commodity and consumer pricing, and market evolution.* Managing a U.S. market entry strategy for a specialty German lighting manufacturer; identified market potential, competitive advantages, and market entry strategies.* Leading an extensive due diligence of a premium apparel manufacturer for a potential private equity investment; identified market and company-specific risks and opportunities.* Developing a competitive assessment of the oncology drug distribution market for a new market entrant post acquisition; identified key strategic and tactical opportunities in the near and long term.* Conducting the due diligence of an environmentally-friendly cleaning and paper products manufacturer for a potential private equity investment; identified market growth drivers and relative positioning of target company.

Leading strategic consulting engagements for local nonprofit organizations

Developed new client relationships and manage project teams, serving as key day-to-day contact with Executive-level clients to frame and solve critical, complex strategic problems primarily in the financial services and not-for-profit industries; member of firm leadership team with responsibility for talent management, including recruiting, staffing, evaluation, and career development. Selected project accomplishments include:* Leading the development of a measurement program with executive-level dashboards to generate fact-based insight and deeper understanding of customer experience for a leading online brokerage.* Managing the development and launch of new customer practice management program for a large financial services organization; coordinated efforts with marketing, sales, product development, and strategy teams; led cross-functional steering committee meetings and working team workshops.* Leading the current assessment (including competitive positioning) and future strategy development of the Designated Brokerage business for a leading online brokerage* Developing a new IT strategy for a leading healthcare non-profit with over 600 volunteers; lead interviews and working sessions with diverse stakeholder groups; developed multi-functional plans to address existing IT gaps; supported RFP and vendor selection process for new website development.

* Account management: Led day-to-day and strategic management of largest channel partner, Advisory Board Company; strengthened communication and coordination between firms; developed plans for future growth.* New product strategy: Developed requirements and business plans for new healthcare provider product ideas in conjunction with marketing, sales, product management, and strategic partners.* Strategic partnerships: Negotiated and finalized contract agreements with new strategic partners; negotiated multi-year contract extension and addendum with Advisory Board to define scope of relationship.

Managed 4-6 person project teams, serving as key contact with VP and Director-level clients to frame and solve critical, complex strategic problems primarily in the healthcare, biotechnology, and pharmaceutical industries; additional experience in many other industries, including technology, logistics, government, finance, and utilities. Selected accomplishments include:* Developing a managed care segmentation, targeting, and activation strategy for a mature biotechnology product in order to increase market share.* Leading a quality improvement training and development program for top executives of national hospital system’s revenue cycle division; estimated cost savings of over $30MM.* Authoring strategic business proposals to strengthen key Monitor client relationships, addressing client needs, and driving revenue growth.* Developing several components of a top biotechnology company’s information strategy, including initial gap analysis, plan to address needs, and delivery channel (web, email, etc.) assessment.* Managing software development teams, working with clients and subject matter experts to develop web applications based on Monitor’s intellectual property.* Actively promoting Monitor’s culture by leading US GLBT recruiting, planning regional networking events, contributing to pro-bono projects, and speaking at conferences on firm’s behalf.* Designing and managing training and orientation for new US consultants.

* Analyzed financial performance of over fifty fixed income accounts and explained results to clients, portfolio managers, and firm management through the use of custom designed spreadsheets.* Researched and reconciled discrepancies between external accounting system, internal databases, and custodian bank statements.* Supervised and trained junior employees, college interns, and Certified Public Accountants.